153 related articles for article (PubMed ID: 23715774)
1. Body iron stores and the risk of type 2 diabetes in middle-aged men.
Aregbesola A; Voutilainen S; Virtanen JK; Mursu J; Tuomainen TP
Eur J Endocrinol; 2013 Aug; 169(2):247-53. PubMed ID: 23715774
[TBL] [Abstract][Full Text] [Related]
2. Excess body iron and the risk of type 2 diabetes mellitus: a nested case-control in the PREDIMED (PREvention with MEDiterranean Diet) study.
Arija V; Fernández-Cao JC; Basora J; Bulló M; Aranda N; Estruch R; Martínez-González MA; Salas-Salvadó J
Br J Nutr; 2014 Dec; 112(11):1896-904. PubMed ID: 25322842
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of iron metabolism are independently associated with impaired glucose metabolism and type 2 diabetes: the KORA F4 study.
Huth C; Beuerle S; Zierer A; Heier M; Herder C; Kaiser T; Koenig W; Kronenberg F; Oexle K; Rathmann W; Roden M; Schwab S; Seissler J; Stöckl D; Meisinger C; Peters A; Thorand B
Eur J Endocrinol; 2015 Nov; 173(5):643-53. PubMed ID: 26294793
[TBL] [Abstract][Full Text] [Related]
4. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women.
Jiang R; Manson JE; Meigs JB; Ma J; Rifai N; Hu FB
JAMA; 2004 Feb; 291(6):711-7. PubMed ID: 14871914
[TBL] [Abstract][Full Text] [Related]
5. Soluble transferrin receptor and risk of type 2 diabetes in the obese and nonobese.
Fernández-Cao JC; Arija V; Aranda N; Basora J; Diez-Espino J; Estruch R; Fitó M; Corella D; Salas-Salvadó J
Eur J Clin Invest; 2017 Mar; 47(3):221-230. PubMed ID: 28075490
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in type 2 diabetes and the role of body iron stores.
Aregbesola A; Voutilainen S; Virtanen JK; Mursu J; Tuomainen TP
Ann Clin Biochem; 2017 Jan; 54(1):113-120. PubMed ID: 27166309
[TBL] [Abstract][Full Text] [Related]
7. Iron deficiency in early pregnancy using serum ferritin and soluble transferrin receptor concentrations are associated with pregnancy and birth outcomes.
Khambalia AZ; Collins CE; Roberts CL; Morris JM; Powell KL; Tasevski V; Nassar N
Eur J Clin Nutr; 2016 Mar; 70(3):358-63. PubMed ID: 26373962
[TBL] [Abstract][Full Text] [Related]
8. Serum fructosamine and risk of type 2 diabetes mellitus among middle-age Finnish men: a 23-year population-based prospective study.
Zaccardi F; Kurl S; Pitocco D; Ronkainen K; Laukkanen JA
Acta Diabetol; 2015 Feb; 52(1):161-6. PubMed ID: 25026924
[TBL] [Abstract][Full Text] [Related]
9. Association between direct measurement of active serum calcium and risk of type 2 diabetes mellitus: A prospective study.
Zaccardi F; Webb DR; Carter P; Pitocco D; Khunti K; Davies MJ; Kurl S; Laukkanen JA
Nutr Metab Cardiovasc Dis; 2015 Jun; 25(6):562-8. PubMed ID: 25933474
[TBL] [Abstract][Full Text] [Related]
10. Association of Body Iron Metabolism with Type 2 Diabetes Mellitus in Chinese Women of Childbearing Age: Results from the China Adult Chronic Disease and Nutrition Surveillance (2015).
Feng J; Shan X; Wang L; Lu J; Cao Y; Yang L
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111154
[TBL] [Abstract][Full Text] [Related]
11. Soluble transferrin receptors and ferritin in Type 2 diabetic patients.
Hernández C; Lecube A; Carrera A; Simó R
Diabet Med; 2005 Jan; 22(1):97-101. PubMed ID: 15606699
[TBL] [Abstract][Full Text] [Related]
12. Association between body iron stores and the risk of acute myocardial infarction in men.
Tuomainen TP; Punnonen K; Nyyssönen K; Salonen JT
Circulation; 1998 Apr; 97(15):1461-6. PubMed ID: 9576426
[TBL] [Abstract][Full Text] [Related]
13. Serum transferrin receptor, serum ferritin and serum transferrin receptor-ferritin index in adults with iron deficiency anaemia.
Nadeem S; Shah S; Iqbal T; Iqbal Z; Hanif E
J Ayub Med Coll Abbottabad; 2011; 23(3):44-6. PubMed ID: 23272433
[TBL] [Abstract][Full Text] [Related]
14. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes.
Mojiminiyi OA; Marouf R; Abdella NA
Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):559-66. PubMed ID: 18063352
[TBL] [Abstract][Full Text] [Related]
15. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis.
Yeap BB; Divitini ML; Gunton JE; Olynyk JK; Beilby JP; McQuillan B; Hung J; Knuiman MW
Clin Endocrinol (Oxf); 2015 Apr; 82(4):525-32. PubMed ID: 24953981
[TBL] [Abstract][Full Text] [Related]
16. Serum soluble transferrin receptor concentrations are increased in central obesity. Results from a screening programme for hereditary hemochromatosis in men with hyperferritinemia.
Freixenet N; Remacha A; Berlanga E; Caixàs A; Giménez-Palop O; Blanco-Vaca F; Bach V; Baiget M; Sánchez Y; Félez J; González-Clemente JM
Clin Chim Acta; 2009 Feb; 400(1-2):111-6. PubMed ID: 19000667
[TBL] [Abstract][Full Text] [Related]
17. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study.
Montonen J; Boeing H; Steffen A; Lehmann R; Fritsche A; Joost HG; Schulze MB; Pischon T
Diabetologia; 2012 Oct; 55(10):2613-2621. PubMed ID: 22752055
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of body iron stores and risk of developing type 2 diabetes.
Rajpathak SN; Wylie-Rosett J; Gunter MJ; Negassa A; Kabat GC; Rohan TE; Crandall J;
Diabetes Obes Metab; 2009 May; 11(5):472-9. PubMed ID: 19207293
[TBL] [Abstract][Full Text] [Related]
19. Progression from impaired fasting glucose to type 2 diabetes mellitus among Chinese subjects with and without hypertension in a primary care setting.
Fu SN; Luk W; Wong CK; Cheung KL
J Diabetes; 2014 Sep; 6(5):438-46. PubMed ID: 24393475
[TBL] [Abstract][Full Text] [Related]
20. Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.
Podmore C; Meidtner K; Schulze MB; Scott RA; Ramond A; Butterworth AS; Di Angelantonio E; Danesh J; Arriola L; Barricarte A; Boeing H; Clavel-Chapelon F; Cross AJ; Dahm CC; Fagherazzi G; Franks PW; Gavrila D; Grioni S; Gunter MJ; Gusto G; Jakszyn P; Katzke V; Key TJ; Kühn T; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sánchez-Cantalejo E; Slimani N; Sluijs I; Spijkerman AM; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; Feskens EJ; Forouhi NG; Sharp SJ; Riboli E; Langenberg C; Wareham NJ
Diabetes Care; 2016 Apr; 39(4):572-81. PubMed ID: 26861925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
